Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

72 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real-world clinical outcomes of patients with stage I HER2-positive breast cancer treated with adjuvant paclitaxel and trastuzumab.
Debien V, Marta GN, Agostinetto E, Sirico M, Jacobs F, Molinelli C, Moreau M, Paesmans M, De Giorgi U, Santoro A, Taylor D, Duhoux FP, Botticelli A, Barchiesi G, Speranza I, Lambertini M, Wildiers H, Azambuja E, Piccart M. Debien V, et al. Among authors: agostinetto e. Crit Rev Oncol Hematol. 2023 Oct;190:104089. doi: 10.1016/j.critrevonc.2023.104089. Epub 2023 Aug 9. Crit Rev Oncol Hematol. 2023. PMID: 37562696 Review.
Predictive Factors of Eribulin Activity in Metastatic Breast Cancer Patients.
De Sanctis R, Agostinetto E, Masci G, Ferraro E, Losurdo A, Viganò A, Antunovic L, Zuradelli M, Torrisi RMC, Santoro A. De Sanctis R, et al. Among authors: agostinetto e. Oncology. 2018;94 Suppl 1(Suppl 1):19-28. doi: 10.1159/000489065. Epub 2018 Jul 23. Oncology. 2018. PMID: 30036884 Free PMC article.
Prognostic factors and outcome of HER2+ breast cancer with CNS metastases.
Masci G, Agostinetto E, Giordano L, Bottai G, Torrisi R, Losurdo A, De Sanctis R, Navarria P, Scorsetti M, Zuradelli M, de Rose F, Bello L, Santoro A. Masci G, et al. Among authors: agostinetto e. Future Oncol. 2020 Mar;16(7):269-279. doi: 10.2217/fon-2019-0602. Epub 2020 Feb 11. Future Oncol. 2020. PMID: 32043375
Biological Characteristics and Long-term Outcomes in Node-negative Breast Cancer.
Agostinetto E, Giordano L, Torrisi R, De Sanctis R, Masci G, Losurdo A, Zuradelli M, Tinterri C, Gatzemeier W, Testori A, Alloisio M, De Rose F, Fernandes B, Santoro A. Agostinetto E, et al. Clin Breast Cancer. 2020 Aug;20(4):e481-e489. doi: 10.1016/j.clbc.2020.02.011. Epub 2020 Mar 6. Clin Breast Cancer. 2020. PMID: 32279915
72 results